; and (B) a review of emerging evidence with respect to perfluoroalkyl or polyfluoroalkyl substances that is impactful in decisionmaking; and (3) (A) whether certain perfluoroalkyl or polyfluoroalkyl substances in certain consumer products pose an unreasonable risk to consumers, such as risks due to perfluoroalkyl or polyfluoroalkyl substance toxicity, persistence, or bioaccumulation; (B) the contribution of the uses identified under subparagraph (A) to the cumulative impact of perfluoroalkyl or polyfluoroalkyl substances on the environment and public health; and (C) recommendations for possible methods to eliminate perfluoroalkyl or polyfluoroalkyl substances from consumer products described in subparagraph (A). (e) Community engagement In carrying out reviews and studies under this section, the National Academies shall integrate robust, transparent, meaningful, and public community outreach. (f) Cooperation of Federal agencies The head of each relevant Federal agency, including the Administrator, shall cooperate fully with the National Academies in carrying out the agreement under subsection (b). (g) Recommendations for additional studies (1) In general The National Academies shall make any recommendations for additional scientific studies determined appropriate by the National Academies to resolve areas of continuing scientific uncertainty relating to essential uses of perfluoroalkyl or polyfluoroalkyl substances. (2) Requirements In making recommendations under paragraph (1), the National Academies shall consider— (A) the scientific information that is available at the time of the recommendation; (B) the value and relevance of the information that could result from additional studies